This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.


Prof. Dr. Gundram Jung:

Publications (selection of important publications)


Hofmann M, Große-Hovest L, Bässler T, Pyz E, Bamberg ML, Aulwurm S, Bühring H-J, Schwartz K, Haen S, Schilbach K, Rammensee H-G, Salih HR and Jung G. Generation, selection and preclinical characterization of an Fc-optimized FLT3-antibody for the treatment of myeloid leukemia. Leukemia 26:1228-1237 (2012)

Große-Hovest L, Müller S, Minoia R, Wolf E, Zakhartchenko V, Wenigerkind H, Lassnig C, Besenfelder U, Müller M, Lytton SD, Jung G, Brem G. Cloned transgenic farm animals produce a bispecific antibody for T cell mediated tumor cell killing. Proc Natl Acad Sci USA 101,6858-6863 (2004)

Große-Hovest L, Hartlapp I, Marwan W, Brem G, Rammensee HG, Jung G. A recombinant bispecific single chain antibody induces targeted, supra-agonistic CD28 stimulation and tumor cell killing. Eur J Immunol 33, 1334-1340 (2003)

Jung G, Große-Hovest L, Krammer PH, Rammensee HG. Target cell restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments. Cancer Res 61,1846-1848 (2001)

Jung G, Brandl M, Eisner W, Fraunberger P, Reifenberger G, Schlegel U, Wiestler OD, Reulen HJ, Wilmanns W. Local immunotherapy of glioma patients with a combination of two bispecific antibody fragments and autologous lymphocytes: Evidence for in situ T-cell activation and therapeutic efficacy. Int J Cancer 91,225-230 (2001)

Jung G, Freimann U, v.Marschall Z, Reisfeld RA and Wilmanns W. Target cell induced T cell activation with bi- and trispecific antibody fragments. Eur J Immunol 21,2431-2435 (1991)

Jung G, Ledbetter JA, Müller-Eberhard HJ. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. Proc Natl Acad Sci USA 84,4611-4615 (1987)

Jung G., Honsik CJ, Reisfeld RA, Müller-Eberhard HJ. Activation of human peripheral blood mononuclear cells by anti-T3: Killing of tumor target cells coated with anti-target X anti-T3-conjugates. Proc Natl Acad Sci USA 83,4479-4483 (1986)